NOT-CA-10-018: Clarification of the Budget Format to be used for the Innovative Molecular Analysis Technologies (IMAT) RFA-CA-10-002 (R33) and RFA-CA-10-004 (R33)

Clarification of Budget Form for the Innovative Molecular Analysis Technologies (IMAT) RFA-CA-10-002 (R33) and RFA-CA-10-004 (R33)

Notice Number: NOT-CA-10-018

Key Dates
Release Date: February 19, 2010

Issued by
National Cancer Institute (NCI) (http://cancer.gov/)

Purpose

The purpose of this Notice is to clarify the Budget Form to be used for the Innovative Molecular Analysis Technologies (IMAT)

RFA-CA-10-002 Validation and Advanced Development of Emerging Technologies in Biospecimen Science (R33)
RFA-CA-10-004 Validation and Advanced Development of Emerging Technologies for Cancer Research (R33)

For both RFAs, ALL applicants (domestic or foreign) must submit a detailed (non-modular) budget using the R&R Budget form.

Section II. Award Information, 1. Mechanism of Support should correctly read:

This FOA uses “Just-in-Time” information concepts (see SF424 (R&R) Application Guide). The detailed (non-modular) R&R Budget form should be used.

Section IV. Application and Submission Information, 2. Content and Form of Application Submission should correctly read:

Required Components:
PHS398 Research & Related Budget

All other aspects of the RFA-CA-10-002 and RFA-CA-10-004 remain unchanged.

Inquiries

Mark David Lim, Ph.D.
Office of the Director, Office of Technology and Industrial Relations
National Cancer Institute (NCI)
Building 31 Center Drive, Room 10A03, MSC 2580
Bethesda, MD 20892-2580
Telephone: (301) 496-1550
Fax: (301) 480-4814
Email: [email protected]

Or

Emily Tran
Office of Grants Administration
National Cancer Institute (NCI)
6120 Executive Boulevard, EPS Suite 243, MSC 7150
Bethesda, MD 20892-7150
Phone: (301) 496-7249
Fax: (301) 496-8601
E-mail: [email protected]